help button home button
AJRCMB
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

Published ahead of print on January 13, 2006, doi:10.1165/rcmb.2005-0228OC
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
2005-0228OCv1
34/5/609    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Koetzler, R.
Right arrow Articles by Green, F. H. Y.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Koetzler, R.
Right arrow Articles by Green, F. H. Y.
American Journal of Respiratory Cell and Molecular Biology. Vol. 34, pp. 609-615, 2006
© 2006 American Thoracic Society
DOI: 10.1165/rcmb.2005-0228OC

Surfactant as an Airway Smooth Muscle Relaxant

Rommy Koetzler, Mahmoud Saifeddine, Zhenguo Yu, F.Samuel Schürch, Morley D. Hollenberg and Francis H. Y. Green

Department of Pathology and Laboratory Medicine, Department of Pharmacology & Therapeutics and Department of Medicine, and Department of Physiology and Biophysics, University of Calgary, Faculty of Medicine, Calgary, Alberta, Canada

Correspondence and requests for reprints should be addressed to Francis H. Y. Green, M.D., Professor, Department of Pathology & Laboratory Medicine, Faculty of Medicine, University of Calgary, 3330 Hospital Drive N.W., Calgary, AB T2N 4N1 Canada. E-mail: fgreen{at}ucalgary.ca

A variety of clinical and experimental evidence indicates that surfactant may be important in the pathogenesis and treatment of asthma. The purpose of this study was to determine the pharmacologic effect of pulmonary surfactant and its major lipid and protein constituents on bronchial smooth muscle. First-generation bronchi from male Sprague-Dawley rats were contracted with methacholine and exposed to two kinds of surfactant: whole rat surfactant and two bovine surfactant extracts in clinical use. The latter lack the hydrophilic surfactant-associated proteins (SP)-A and SP-D. All the surfactants relaxed the rat bronchi in a concentration-dependent manner; however, whole rat surfactant was more potent than the bovine extracts. Both surfactant lipids and SP-A contributed to the bronchial relaxation. The relaxation response produced by the highest concentration (0.5 mg/ml) of whole rat surfactant was equivalent to that caused by substance P (5 µM) and approximately half of that caused by 1 µM isoproterenol. The relaxation response was epithelium-dependent and blocked by indomethacin but not by N-{omega}-nitro-L-arginine methyl ester. We conclude that surfactant can relax airway smooth muscle directly via a prostanoid-mediated, epithelium-dependent process that does not involve nitric oxide synthase.

Key Words: asthma • nitric oxide • prostaglandins • smooth muscle • surfactant







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Proc. Am. Thorac. Soc. Am. J. Respir. Crit. Care Med.
Copyright © 2006 American Thoracic Society.